126 related articles for article (PubMed ID: 23813330)
1. Contribution of renal and non-renal clearance on increased total clearance of adalimumab in glomerular disease.
Roberts BV; Susano I; Gipson DS; Trachtman H; Joy MS
J Clin Pharmacol; 2013 Sep; 53(9):919-24. PubMed ID: 23813330
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.
Joy MS; Gipson DS; Powell L; MacHardy J; Jennette JC; Vento S; Pan C; Savin V; Eddy A; Fogo AB; Kopp JB; Cattran D; Trachtman H
Am J Kidney Dis; 2010 Jan; 55(1):50-60. PubMed ID: 19932542
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
Trachtman H; Vento S; Herreshoff E; Radeva M; Gassman J; Stein DT; Savin VJ; Sharma M; Reiser J; Wei C; Somers M; Srivastava T; Gipson DS
BMC Nephrol; 2015 Jul; 16():111. PubMed ID: 26198842
[TBL] [Abstract][Full Text] [Related]
4. Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration?
Yu Y; Hinderling PH
Int J Clin Pharmacol Ther; 2024 Mar; 62(3):129-141. PubMed ID: 38174884
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Assessment of the Effect of Chronic Kidney Disease on the Nonrenal Clearance of 10 Drugs After Intravenous Administration.
Hinderling PH; Yu Y
Clin Pharmacol Drug Dev; 2019 Feb; 8(2):138-151. PubMed ID: 30589517
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.
Peyser A; Machardy N; Tarapore F; Machardy J; Powell L; Gipson DS; Savin V; Pan C; Kump T; Vento S; Trachtman H
BMC Nephrol; 2010 Jan; 11():2. PubMed ID: 20113498
[TBL] [Abstract][Full Text] [Related]
7. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
[TBL] [Abstract][Full Text] [Related]
8. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans.
Sjöström P; Tidman M; Jones I
Scand J Clin Lab Invest; 2005; 65(2):111-24. PubMed ID: 16025834
[TBL] [Abstract][Full Text] [Related]
9. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
10. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
Trachtman H; Fervenza FC; Gipson DS; Heering P; Jayne DR; Peters H; Rota S; Remuzzi G; Rump LC; Sellin LK; Heaton JP; Streisand JB; Hard ML; Ledbetter SR; Vincenti F
Kidney Int; 2011 Jun; 79(11):1236-43. PubMed ID: 21368745
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin in children and young adults with focal segmental glomerulosclerosis.
Sethna CB; Boone V; Kwok J; Jun D; Trachtman H
Pediatr Nephrol; 2015 Nov; 30(11):1977-85. PubMed ID: 26115618
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study.
Rajasekeran H; Reich HN; Hladunewich MA; Cattran D; Lovshin JA; Lytvyn Y; Bjornstad P; Lai V; Tse J; Cham L; Majumder S; Bowskill BB; Kabir MG; Advani SL; Gibson IW; Sood MM; Advani A; Cherney DZI
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F412-F422. PubMed ID: 29141939
[TBL] [Abstract][Full Text] [Related]
13. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
Youssef DM; El-Shal AA
Iran J Kidney Dis; 2012 Sep; 6(5):355-60. PubMed ID: 22976261
[TBL] [Abstract][Full Text] [Related]
14. Famotidine disposition in children and adolescents with chronic renal insufficiency.
Maples HD; James LP; Stowe CD; Jones DP; Hak EB; Blumer JL; Vogt B; Wilson JT; Kearns GL; Wells TG;
J Clin Pharmacol; 2003 Jan; 43(1):7-14. PubMed ID: 12520622
[TBL] [Abstract][Full Text] [Related]
15. Aging effects on the organic base transporter and stereoselective renal clearance.
Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
[TBL] [Abstract][Full Text] [Related]
16. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
17. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
18. Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
Chiu YL; Rubin DT; Vermeire S; Louis E; Robinson AM; Lomax KG; Pollack PF; Paulson SK
Inflamm Bowel Dis; 2013 May; 19(6):1112-22. PubMed ID: 23584130
[TBL] [Abstract][Full Text] [Related]
19. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
20. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
Rong LP; Chen LZ; Fu Q; Chen WF; Sun LZ; Jiang XY; Mo Y
Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):936-940. PubMed ID: 27938596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
